Whalesbook
Technical Breakout Sparks Rally
CARE Ratings Ltd. shares have risen significantly, breaking past the upper line of a symmetrical triangle pattern on daily charts. This signals a stronger bullish trend, further supported by a nearing "Golden Cross"—where the 50-day moving average is set to cross above the 200-day moving average. The stock has shown resilience, bouncing off key moving averages. This momentum has pushed shares up over 7% last month. CARE Ratings is currently trading above most short and long-term moving averages, including the 5, 10, 30, 50, 100, and 200-day DMAs. The daily RSI is near 68, showing strong buying interest and positive momentum. Analysts see potential upside to Rs 1,920-2,080.
Valuation vs. Peers and Sector Outlook
Comparing CARE Ratings' valuation to peers shows a more complex picture. The company trades at a higher price-to-earnings (P/E) multiple of approximately 29-32x (as of May 2026) than ICRA Ltd., which trades around 27-28x. CRISIL Ltd., a larger firm with a market cap near ₹30,000 crore, has a higher P/E ratio of around 36-37x. This positions CARE Ratings between peers on valuation. Forecasts suggest bank credit growth may slow to 11.0-11.7% in FY2027, due to geopolitical uncertainty and changing interest rates. Rating agencies like ICRA and Fitch Ratings predict challenges from higher oil prices, which could impact India's current account deficit and domestic spending, potentially reducing demand for credit ratings.
Key Resistance and Valuation Worries
Despite the recent breakout, CARE Ratings stock has struggled to hold above Rs 1,964, a level reached in June 2025, acting as key resistance. A drop of over 8% from that peak to Rs 1,801 by May 2026 highlights the difficulty in surpassing previous highs. The current P/E ratio of around 29-32x indicates the market may already price in high optimism, particularly with banking sector credit growth expected to slow. The wider industry faces external pressures like geopolitical tensions and volatile energy prices, which could slow company expansion and thus the need for credit ratings. This calls for caution, with analysts recommending a strict stop-loss of Rs 1,690.
Analyst Views on Outlook
Analysts remain bullish in the short term, setting targets between Rs 1,920 and Rs 2,080, depending on continued technical momentum and a confirmed Golden Cross. The stock trading above key moving averages and a strong RSI support this positive view. However, the stock's sustained rise will depend on how well CARE Ratings manages slowing credit growth and broader economic uncertainties.